Drug Shortage Report for CASPOFUNGIN FOR INJECTION

Last updated on 2021-11-04 History
Report ID 148860
Drug Identification Number 02486989
Brand name CASPOFUNGIN FOR INJECTION
Common or Proper name Caspofungin for Injection 50 mg Vial 10 mL
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) CASPOFUNGIN
Strength(s) 50MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 mL
ATC code J02AX
ATC description ANTIMYCOTICS FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-11-02
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2021-11-04
Company comments On 100% allocation.
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2021-11-04 French Compare
v1 2021-11-04 English Compare